US 8084250
Defensin-antigen fusion proteins
granted A61KA61K31/7088A61K38/00
Quick answer
US patent 8084250 (Defensin-antigen fusion proteins) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/7088, A61K38/00, A61K38/19, A61K39/00117